MarketsandMarkets: Obama's Healthcare Reform Bill and its Impact on the U.S. Healthcare Market (Pharmaceuticals, Medical Devices and Health Insurance)

DALLAS, Texas, August 10, 2010 - This report forecasts the future impacts of the Health Reform bill
enacted by President Obama in March 2010. The report focuses on the U.S.
healthcare system and its major stakeholders such as pharmaceutical
manufacturers, medical devices manufacturers, and health insurance industry.

Browse in-depth TOC on Obama's Healthcare Reform Bill and its impact on
the U.S. Healthcare Market. Early buyers will receive 10% customization of
reports
www.marketsandmarkets.com/Market-Reports/Impact-Obama-Health-US-240.ht
ml

(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)

The health reform bill set forth several provisions to improve
the quality and efficiency of healthcare, address the inefficiencies of the
existing healthcare structure, and to decrease the number of uninsured people
in the U.S. In order to implement a self-funded reform, the Obama
Administration set forward provisions for cost containment and assessment of
annual fees (in the form of excise tax) on drug manufacturers, medical device
companies, and the private insurance industry over a period of 2010 to 2019.
Successful implementation of the health reforms by 2019 would reduce federal
budgetary deficit by $143 billion from about $1.4 trillion in 2009.

The industry-specific provisions of the health reforms are
expected to have a mixed impact on drug manufacturers and medical device
industry. Evaluating the health reforms from the perspective of changing
equation among industry stakeholders, empowerment of consumers in the long
run is likely to create a win-win situation for all stakeholders.

Scope and Format

The report forecasts and analyzes the future impact of the
health reforms on the U.S. healthcare industry. This covers direct as well as
indirect impacts of the provisions on pharmaceutical, medical devices, and
health insurance industries. Indirect impact refers to provisions that do not
specifically apply to these industries. Each section offers a strategic
analysis of the impact of Obama's health reforms on the U.S. healthcare
structure.

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting
company based in the U.S. We publish strategically analyzed market research
reports and serve as a business intelligence partner to Fortune 500 companies
across the world. MarketsandMarkets also provides multi-client reports,
company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials,
automotive and transportation, banking and financial services, biotechnology,
chemicals, consumer goods energy and power, food and beverages, industrial
automation, medical devices, pharmaceuticals, semiconductor and electronics,
and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by
providing apt business insight with our huge market intelligence repository.
To know more about us and our reports, please visit our website
www.marketsandmarkets.com

    Contact:
    Ms. Sunita
    7557 Rambler Road
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com

    www.marketsandmarkets.com
    marketsandmarkets.wordpress.com/
    marketsandmarkets.blogspot.com/

Contact: Ms. Sunita, 7557 Rambler Road, Suite 727, Dallas, TX 75231, Tel: +1-888-989-8004, Email: sales at marketsandmarkets.com